India has marked a significant milestone in global eye care as the WHO redesignates the L V Prasad Eye Institute as the Centre for Prevention of Blindness until 2030
India’s healthcare ecosystem is witnessing a steady transformation, driven by rising research and development (R&D) initiatives and increased investments in scientific infrastructure
Godavari Biorefineries has achieved a milestone in the global battle against cancer with the Japanese patenting of its anti-cancer molecule
India's medical device industry is on track for a major transformation. A new report by Bain & Company says the sector could unlock a USD 35 billion opportunity by 2030, making it one of the fastest-growing segments of India's healthcare ecosystem.
India is set to become one of the earliest markets for Novo Nordisk's breakthrough once-weekly insulin,The Danish drug maker is preparing to launch Awiqli after securing regulatory approval.
Marksans Pharma has taken another step to expand its Europe presence by signing a deal to acquire Germany-based ABCnow GmbH.
AI healthcare growth is turning India into one of the world's biggest centers for medical technology innovation.
Researchers have developed a new one injection treatment that could reduce the need for osteoarthritis surgery in the future.
The Pharma Industry witnessed another eventful week, with developments across regulation, innovation, manufacturing, and public health.
1.jpg)
The government sets new regulatory rules on drug launches, that relieves the hurdles for Indian manufacturers in obtaining regulatory approvals for supply delays. This in turn, aims to improve the quick market entry of drugs and improve sales
, CDSCO.jpg)
